Streetbeat News

Analyst Ratings

COTY

In the last quarter, Coty (NYSE:COTY) received 2 somewhat bullish and 10 indifferent analyst ratings. The company's average 12-month price target is $12.19, a decrease of 6.01% from the previous average of $12.97. Analysts arrive at their conclusions by predicting a company's future earnings and the predictability of its revenue streams.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 1:00 pm

HBAN

Over the past 3 months, 3 analysts have published their opinion on Huntington Bancshares (NASDAQ:HBAN) stock. The analysts have an average price target of $12.0 versus the current price of Huntington Bancshares at $9.65. This current average has decreased by 5.88% from the previous average price target of $12.75.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 1:00 pm

MOS

Analysts have provided mixed ratings for Mosaic (NYSE:MOS) in the last quarter, with 2 bullish, 6 indifferent, and 2 somewhat bearish. The average 12-month price target is $41.4, representing a 0.74% decrease from the previous average price target of $41.71.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 1:00 pm

IONS

In the last quarter, Ionis Pharmaceuticals (NASDAQ:IONS) received 7 analyst ratings, with 4 being bullish, 1 somewhat bullish, and 2 indifferent. Over the past 3 months, 7 analysts have offered 12-month price targets for Ionis Pharmaceuticals, with an average price target of $57.86, a high of $65.00, and a low of $45.00. The average price target has increased by 56.38% over the past month.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 1:00 pm

BKNG

Analysts have provided various ratings for Booking Holdings (NASDAQ:BKNG) within the last quarter, with a majority leaning towards bullish. The average 12-month price target for Booking Holdings has increased by 13.14% from the previous average price target of $3127.70 to $3538.82.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 1:00 pm

NEO

Goldman Sachs analyst Matthew Sykes has maintained a 'Buy' rating on NeoGenomics (NASDAQ:NEO) but lowered the price target from $19 to $17.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:00 pm

OKTA

25 analysts have provided ratings for Okta (NASDAQ:OKTA) over the last quarter, with a majority being bullish or somewhat bullish. The average price target is $93.48, indicating an upside from the current price of $69.25. The average price target has increased by 8.31% over the past month.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 1:00 pm

NTRA

Goldman Sachs analyst Matthew Sykes has maintained a 'Buy' rating on Natera (NASDAQ:NTRA) but lowered the price target from $60 to $52.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 12:57 pm

HXL

Hexcel Corporation (NYSE:HXL) is expected to report higher Q3 earnings of 43 cents per share, up from 33 cents per share a year ago. The company's revenue is projected to be $427.28 million, compared to $398.06 million in the same period last year. Several analysts have recently adjusted their price targets for Hexcel, with the most accurate analyst, from Wolfe Research, upgrading the stock to Outperform with a price target of $83.

Portfolio Pulse from Lisa Levin

October 23, 2023 | 12:56 pm

ULTA

Raymond James analyst Olivia Tong has maintained a 'Strong Buy' rating on Ulta Beauty (NASDAQ:ULTA), but lowered the price target from $550 to $500.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 12:56 pm